• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Japan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery - Product Image

Japan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

  • ID: 2011715
  • December 2011
  • Region: Japan
  • 93 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • ARKRAY, Inc.
  • Bayer HealthCare AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • LifeScan, Inc.
  • MORE

Japan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Summary

GlobalData’s new report, “Japan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery” provides key market data on the Japan Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • ARKRAY, Inc.
  • Bayer HealthCare AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • LifeScan, Inc.
  • MORE

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Diabetes Care Devices In Japan
3.1 Diabetes Care Devices, Market Segmentation
3.2 Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, 2003-2017
3.3 Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2010
3.4 Diabetes Care Devices Market, Japan, Category Contribution (%), 2010
3.5 Diabetes Care Devices, Japan, Category Volume (Units), 2003-2017
3.6 Diabetes Care Devices, Japan, Company Share (2009-2010)
4 Glucose Monitoring In Japan
4.1 Glucose Monitoring, Market Segmentation
4.2 Glucose Monitoring Market, Japan, Revenue Mix ($m), 2010
4.3 Glucose Monitoring Market, Japan, Segment Contribution (%), 2010
4.4 Glucose Monitoring Overall Revenue (2003-2017)
4.4.1 Blood Glucose Meters Revenue (2003-2017)
4.5 Glucose Monitoring Overall Volume (2003-2017)
4.5.1 Blood Glucose Meters Volume (2003-2017)
4.6 Glucose Monitoring Average Price (2003-2017)
4.7 Glucose Monitoring Distribution Share (2009-2010)
4.8 Glucose Monitoring, Japan, Company share (2009-2010)
5 Insulin Delivery In Japan
5.1 Insulin Delivery, Market Segmentation
5.2 Insulin Delivery Market, Japan, Revenue Mix ($m), 2010
5.3 Insulin Delivery Market, Japan, Segment Contribution (%), 2010
5.4 Insulin Delivery Overall Revenue (2003-2017)
5.4.1 Insulin Pens Revenue (2003-2017)
5.4.2 Insulin Pumps Revenue (2003-2017)
5.5 Insulin Delivery Overall Volume (2003-2017)
5.5.1 Insulin Pens Volume (2003-2017)
5.5.2 Insulin Pumps Volume (2003-2017)
5.6 Insulin Delivery Average Price (2003-2017)
5.7 Insulin Delivery Distribution Share (2009-2010)
5.8 Insulin Delivery, Japan, Company share (2009-2010)
6 Overview of Key Companies in Japan Diabetes Care Devices Market
6.1 LifeScan, Inc.
6.1.1 Company Overview
6.1.2 Share in the Japan Diabetes Care Devices Market
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Share in the Japan Diabetes Care Devices Market
6.3 Novo Nordisk A/S
6.3.1 Company Overview
6.3.2 Share in the Japan Diabetes Care Devices Market
6.4 ARKRAY, Inc.
6.4.1 Company Overview
6.4.2 Share in the Japan Diabetes Care Devices Market
6.5 Eli Lilly and Company
6.5.1 Company Overview
6.5.2 Share in the Japan Diabetes Care Devices Market
6.6 Sanofi
6.6.1 Company Overview
6.6.2 Share in the Japan Diabetes Care Devices Market
6.7 Abbott Laboratories
6.7.1 Company Overview
6.8 Medtronic, Inc.
6.8.1 Company Overview
6.9 Terumo Corporation
6.9.1 Company Overview
6.10 Bayer HealthCare AG
6.10.1 Company Overview
6.11 NIPRO CORPORATION
6.11.1 Company Overview
7 Diabetes Care Devices Market Pipeline Products
8 Recent Developments
8.1 Strategy and Business Planning
8.1.1 Nov 04, 2011: Takeda Announces New Structure Of Business Operations
8.1.2 Apr 28, 2011: Takeda Announces Establishment Of New Sales And Marketing Company In China
8.1.3 Mar 25, 2011: Takeda Plans To Expand Sales Force And To Enhance Business Infrastructure In China
8.2 Government and Public Interest
8.2.1 Jun 15, 2011: Takeda To Start Internship Program For Tsinghua University Of China
8.2.2 Feb 21, 2011: Takeda Recalls Anti-Inflammatory Enzyme Preparation, Dasen In Japan
9 Appendix
9.1 Definitions of Markets Covered in the Report
9.1.1 Diabetes Care Devices
9.2 Research Methodology
9.3 Secondary Research
9.4 Primary Research
9.5 Models
9.6 Forecasts
9.7 Expert Panels
9.8 GlobalData Consulting
9.9 Currency Conversion
9.10 Contact Us
9.11 Disclaimer

1.1 List of Tables
Table 1: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, 2003-2017
Table 2: Diabetes Care Devices Market, Japan, Category Contribution (%), 2010
Table 3: Diabetes Care Devices, Japan, Cross-Segment Analysis, 2003-2017
Table 4: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 5: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 6: Diabetes Care Devices, Japan, Category Volume (Units), 2003-2017
Table 7: Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2003-2010
Table 8: Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2010-2017
Table 9: Diabetes Care Devices, Japan, Company Share by Revenue ($m), USD Actual, 2009-2010
Table 10: Glucose Monitoring Market, Japan, Segment Contribution (%), 2010
Table 11: Glucose Monitoring, Japan, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 12: Glucose Monitoring, Japan, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 13: Blood Glucose Meters, Japan, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 14: Blood Glucose Meters, Japan, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 15: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2003-2010
Table 16: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2010-2017
Table 17: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 18: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 19: Glucose Monitoring, Japan, Average Price ($), Historic, 2003-2010
Table 20: Glucose Monitoring, Japan, Average Price ($), Forecast, 2010-2017
Table 21: Glucose Monitoring, Japan, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 22: Glucose Monitoring, Japan, Company share by Revenue ($m), USD Actual 2009-2010
Table 23: Insulin Delivery Market, Japan, Segment Contribution (%), 2010
Table 24: Insulin Delivery, Japan, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 25: Insulin Delivery, Japan, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 26: Insulin Pens, Japan, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 27: Insulin Pens, Japan, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 28: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m), USD Actual, Historic, 2003-2010
Table 29: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m), USD Actual, Forecast, 2010-2017
Table 30: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2003-2010
Table 31: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2010-2017
Table 32: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 33: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 34: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Historic, 2003-2010
Table 35: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Forecast, 2010-2017
Table 36: Insulin Delivery, Japan, Average Price ($), Historic, 2003-2010
Table 37: Insulin Delivery, Japan, Average Price ($), Forecast, 2010-2017
Table 38: Insulin Delivery, Japan, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 39: Insulin Delivery, Japan, Company share by Revenue ($m), USD Actual 2009-2010
Table 40: Diabetes Care Devices Market Pipeline Products
Table 41: USD to Local Currency, Japan, Average Actual Rate 2003-2010

1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation
Figure 2: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, 2003-2017
Figure 3: Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2010
Figure 4: Diabetes Care Devices Market, Japan, Category Contribution (%), 2010
Figure 5: Diabetes Care Devices, Japan, Cross-Segment Analysis, 2003-2017
Figure 6: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 7: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 8: Diabetes Care Devices, Japan, Category Volume (Units), 2003-2017
Figure 9: Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2003-2010
Figure 10: Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2010-2017
Figure 11: Diabetes Care Devices, Japan, Company Share (%), 2010
Figure 12: Glucose Monitoring, Market Segmentation
Figure 13: Glucose Monitoring Market, Japan, Revenue Mix ($m), 2010
Figure 14: Glucose Monitoring Market, Japan, Segment Contribution (%), 2010
Figure 15: Glucose Monitoring, Japan, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 16: Glucose Monitoring, Japan, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 17: Blood Glucose Meters, Japan, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 18: Blood Glucose Meters, Japan, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 19: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2003-2010
Figure 20: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2010-2017
Figure 21: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 22: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 23: Glucose Monitoring, Japan, Company share (%), 2010
Figure 24: Insulin Delivery, Market Segmentation
Figure 25: Insulin Delivery Market, Japan, Revenue Mix ($m), 2010
Figure 26: Insulin Delivery Market, Japan, Segment Contribution (%), 2010
Figure 27: Insulin Delivery, Japan, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 28: Insulin Delivery, Japan, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 29: Insulin Pens, Japan, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 30: Insulin Pens, Japan, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 31: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m), USD Actual, Historic, 2003-2010
Figure 32: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 33: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2003-2010
Figure 34: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2010-2017
Figure 35: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 36: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 37: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Historic, 2003-2010
Figure 38: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Forecast, 2010-2017
Figure 39: Insulin Delivery, Japan, Company share (%), 2010
Figure 40: LifeScan, Inc., Company Share (%),Japan Diabetes Care Devices Market, 2010
Figure 41: F. Hoffmann-La Roche Ltd., Company Share (%),Japan Diabetes Care Devices Market, 2010
Figure 42: Novo Nordisk A/S, Company Share (%),Japan Diabetes Care Devices Market, 2010
Figure 43: ARKRAY, Inc., Company Share (%),Japan Diabetes Care Devices Market, 2010
Figure 44: Eli Lilly and Company, Company Share (%),Japan Diabetes Care Devices Market, 2010
Figure 45: Sanofi, Company Share (%),Japan Diabetes Care Devices Market, 2010

LifeScan, Inc.
F. Hoffmann-La Roche Ltd.
Novo Nordisk A/S
ARKRAY, Inc.
Eli Lilly and Company
Sanofi
Abbott Laboratories
Medtronic, Inc.
Terumo Corporation
Bayer HealthCare AG
NIPRO CORPORATION

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos